Circulating Tumor Cells in Cancer Diagnostics and Prognostics by Single-Molecule and Single-Cell Characterization

Area of Science:

• Oncology
• Biomarker Discovery
• Cell Biology

Background:

• Circulating tumor cells (CTCs) hold potential as biomarkers for cancer diagnosis, prognosis, and recurrence prediction.
• Their diagnostic utility remains unproven due to scarcity in biological fluids, impeding the identification of metastatic subpopulations.
• Identifying these dangerous CTC subpopulations is crucial for understanding and combating metastatic dissemination.

Purpose of the Study:

• To discuss advanced techniques for identifying metastatic circulating tumor cells (CTCs).
• To explore methods for CTC isolation, amplification, and single-cell/molecule analysis.
• To highlight the potential of combining biophysical and molecular analyses for improved cancer diagnostics.

Main Methods:

• Isolation of patient-derived CTCs.
• Utilizing 3D biomimetic matrixes for CTC amplification and analysis.
• Employing single-cell and single-molecule analysis techniques.
• Applying atomic force microscopy for mechanical/morphological properties.
• Using nanopore-based detection for molecular biomarker identification.

Main Results:

• The abstract is a perspective piece, outlining potential methods rather than presenting experimental results.
• It discusses the feasibility and promise of various advanced techniques for CTC analysis.
• It highlights the potential for integrating different methodologies for comprehensive CTC characterization.

Conclusions:

• Advanced techniques, including 3D biomimetic matrixes and single-cell analyses, show promise for overcoming CTC scarcity.
• Combining biophysical (e.g., atomic force microscopy) and molecular (e.g., nanopore detection) analyses could significantly enhance diagnostic accuracy.
• Future integration of these methods may lead to more precise cancer diagnosis and patient management.